![]() |
市場調查報告書
商品編碼
2041626
皮膚影像設備市場預測至2034年-按產品、模式、技術、應用、最終用戶和地區分類的全球分析Dermatology Imaging Devices Market Forecasts to 2034 - Global Analysis By Product, Modality, Technology, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球皮膚成像設備市場規模將達到 130.1 億美元,在預測期內以 14.7% 的複合年成長率成長,到 2034 年將達到 389.6 億美元。
皮膚影像設備在皮膚疾病的診斷和後續觀察中發揮著至關重要的作用。這些設備利用先進技術提供皮膚結構的詳細影像。皮膚科醫生使用這些非侵入性工具來檢查痣、病變和皮膚異常,有助於早期發現皮膚癌和其他皮膚疾病。高解析度影像有助於提高診斷準確性,並有助於制定更有效的治療方案,從而改善皮膚科患者的治療效果。
根據美國癌症協會 2022 年的統計數據,預計 2022 年美國將通報 99,780 例新的皮膚黑色素瘤病例。其中,預計男性病例為 57,180 例,女性病例為 42,600 例。
皮膚病發生率不斷上升
隨著人口老化、生活方式改變和環境污染加劇,皮膚病發病率不斷上升,對精準有效的皮膚病診斷技術的需求也日益成長。醫療專業人員尋求最尖端科技以實現皮膚病的快速精準診斷,皮膚影像設備市場正顯著擴張。這些設備不僅能夠進行非侵入性檢查,促進了市場成長,滿足了皮膚病患者的需求,還有助於提高皮膚科診療的整體效率。
限制進入醫療機構
在醫療基礎設施薄弱的地區,確保患者及時獲得皮膚科診斷和治療是一項挑戰。醫療服務取得方面的不平等加劇了皮膚疾病的負擔,因為患者可能在接受適當的皮膚科治療方面遭遇延誤。這種障礙對服務不足的地區影響尤其嚴重,擴大了醫療保健方面的差距,並阻礙了市場的潛在成長。
人們對美容手術的認知和關注度不斷提高
隨著人們越來越重視皮膚健康和美容,對技術先進的皮膚成像設備的需求也日益成長。這些設備對於識別和追蹤皮膚問題至關重要,能夠幫助專業人士提供精準且個人化的美容療程。在醫療和美容技術融合以及人們對獲得最佳美容效果日益成長的需求的推動下,皮膚成像設備市場預計將持續成長。
先進診斷影像設備高成本
採用和維護最尖端科技的高昂成本限制了醫療專業人員和機構的使用。這種經濟障礙阻礙了科技的普及,也使得小規模診所和機構無法投資最先進的皮膚影像設備。因此,資源分配不均可能阻礙皮膚科先進診斷能力的整體發展和普及,進而影響患者照護和診斷準確性。
新冠疫情的感染疾病
新冠疫情對市場產生了複雜的影響。初期,由於醫療服務中斷以及資源優先用於對抗疫情,市場需求有所下降;但隨著人們的注意力轉向遠端醫療和遠距離診斷,市場逐漸復甦。疫情凸顯了皮膚影像在線上諮詢中的重要性,促使其應用激增。然而,供應鏈中斷和經濟不確定性仍然對皮膚影像設備產業的市場成長構成挑戰。
在預測期內,皮膚鏡領域預計將佔據最大的市場規模。
預計皮膚鏡市場將迎來顯著成長。皮膚鏡是皮膚科醫生用來檢查皮膚病變和異常情況的攜帶式設備。這些放大儀器可以放大皮膚,使專家能夠更清晰地評估痣、色素性病變和其他皮膚狀況。皮膚鏡有多種設計,包括接觸式和非接觸式,在皮膚科診斷中發揮著至關重要的作用,有助於醫生做出更準確、更明智的皮膚健康決策。其便攜性和易用性使其成為日常皮膚檢查中不可或缺的工具。
預計在預測期內,皮膚癌診斷細分市場將呈現最高的複合年成長率。
預計在預測期內,皮膚癌診斷領域將呈現最高的複合年成長率。皮膚影像設備在皮膚癌診斷中發揮著至關重要的作用,它們能夠提供非侵入性、高解析度的皮膚影像。這些設備幫助皮膚科醫師準確評估皮膚病變,區分良性和惡性腫瘤,並確定最佳切片檢查部位。這項技術有助於早期發現,從而實現及時治療性介入,改善預後。此外,這些設備還能最大限度地減少不必要的切片檢查,減輕患者負擔,並降低醫療成本。
預計亞太地區將在預測期內佔據最大的市場佔有率,這主要得益於人們對皮膚健康的日益關注以及皮膚疾病發病率的上升。該地區的領先企業,例如美能達和尼德克公司,正在加大研發投入,以推動診斷影像解決方案的創新。醫療基礎設施的改善和可支配收入的增加也促進了市場擴張。此外,對非侵入性高效診斷工具的需求也推動了市場成長,中國、日本和印度等國家正在成為該地區皮膚科診斷影像設備市場的主要驅動力。
預計北美地區在預測期內將呈現最高的複合年成長率。該地區預計在技術進步和皮膚病患病率上升的推動下實現強勁成長。北美擁有龐大的老齡人口。該地區的新興經濟體,例如美國和加拿大,擁有有利的醫保報銷政策和完善的醫療保健基礎設施。此外,監管支援和醫療保健基礎設施的進步在推動北美蓬勃發展的皮膚影像設備市場中發揮著至關重要的作用。
According to Stratistics MRC, the Global Dermatology Imaging Devices Market is accounted for $13.01 billion in 2026 and is expected to reach $38.96 billion by 2034 growing at a CAGR of 14.7% during the forecast period. Dermatology imaging devices play a crucial role in diagnosing and monitoring skin conditions. These devices utilize advanced technologies to provide detailed images of the skin's structure. Dermatologists use these non-invasive tools to examine moles, lesions, and skin abnormalities, aiding in the early detection of skin cancers and other dermatological issues. The high-resolution imaging helps enhance diagnostic accuracy and facilitates more effective treatment planning, contributing to improved patient outcomes in the field of dermatology.
According to the American Cancer Society's 2022 statistics, in the United States, an estimated 99,780 new cases of melanoma of the skin are expected to be reported in 2022. Of those, 57,180 cases are likely to be registered among males and 42,600 in females.
Growing incidence of skin disorders
Accurate and effective diagnostic techniques are becoming a growing necessity in dermatology as skin disorders grow more common as a result of aging populations, changes in lifestyle, and pollution. As medical professionals look for cutting-edge technologies for accurate and timely diagnosis of skin conditions, the market for dermatology imaging devices is expanding significantly. Contributing to the market's expansion in response to the rising frequency of skin problems, these devices aid in non-invasive inspection, improving the overall efficiency of dermatological practices.
Limited access to healthcare facilities
In regions with restricted healthcare infrastructure, patients face challenges in obtaining timely dermatological diagnoses and treatments. The disparity in healthcare access also exacerbates the burden of skin diseases, as patients may experience delays in receiving proper dermatological care. This barrier disproportionately affects underserved regions, exacerbating healthcare disparities and impeding the market's potential growth.
Rising awareness & focus on aesthetic procedures
Technologically improved imaging instruments in dermatology are in greater demand as people place greater emphasis on skin health and attractiveness. These tools are essential for identifying and tracking skin issues, which helps professionals provide accurate and customized cosmetic procedures. With a heightened focus on achieving optimal cosmetic outcomes, the market for dermatology imaging devices is poised for sustained growth, driven by the intersection of medical and aesthetic advancements.
High cost of advanced imaging devices
The prohibitive expenses associated with acquiring and maintaining cutting-edge technology limit accessibility for healthcare providers and facilities. This financial barrier hampers widespread adoption, hindering smaller clinics and healthcare institutions from investing in state-of-the-art dermatology imaging equipment. As a result, the unequal distribution of resources may impede the overall growth and accessibility of advanced diagnostic capabilities in dermatology, potentially compromising patient care and diagnostic accuracy.
Covid-19 Impact
The covid-19 pandemic has had a mixed impact on the market. While there was an initial decline in demand due to disrupted healthcare services and prioritization of covid-related resources, the market rebounded with an increased focus on telemedicine and remote diagnostics. The pandemic underscored the importance of dermatological imaging for virtual consultations, leading to a surge in adoption. However, supply chain disruptions and economic uncertainties continue to pose challenges for market growth in the dermatology imaging devices sector.
The dermatoscopes segment is expected to be the largest during the forecast period
The dermatoscopes segment is estimated to have a lucrative growth. Dermatoscopes are handheld devices used by dermatologists to examine skin lesions and abnormalities. These magnifying instruments provide a close-up view of the skin, enabling professionals to assess moles, pigmented lesions, and other skin conditions with enhanced clarity. With varying designs, including contact and non-contact models, dermatoscopes play a crucial role in dermatological diagnostics, facilitating more accurate and informed decisions about skin health. Their portability and ease of use make them valuable tools in routine skin examinations.
The skin cancer diagnosis segment is expected to have the highest CAGR during the forecast period
The skin cancer diagnosis segment is anticipated to witness the highest CAGR growth during the forecast period. Dermatology imaging devices play a pivotal role in skin cancer diagnosis by offering non-invasive, high-resolution images of the skin. These devices aid dermatologists in accurately assessing skin lesions, distinguishing benign from malignant growths, and determining optimal biopsy locations. The technology enhances early detection, leading to timely intervention and improved prognosis. Additionally, these devices minimize unnecessary biopsies, reducing patient discomfort and healthcare costs.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the growing awareness of skin health and a rising prevalence of dermatological conditions. Key players here namely Minolta and Nidek Corporation are investing in research and development, fostering innovation in imaging solutions. Also, improvements in healthcare infrastructure and rising disposable incomes contribute to the market expansion. Further, the demand for non-invasive and efficient diagnostic tools is fueling the market's momentum, with countries like China, Japan, and India emerging as key contributors to the region's dermatology imaging devices market.
North America is projected to have the highest CAGR over the forecast period. The region exhibits robust growth driven by technological advancements and a rising prevalence of skin disorders. North America has the presence of huge aging population. Emerging economies in the region such as United States and Canada has favourable reimbursement policies and a well-established healthcare infrastructure. Moreover, regulatory support and healthcare infrastructure advancements also play pivotal roles in shaping the thriving dermatology imaging devices market in North America.
Key players in the market
Some of the key players profiled in the Dermatology Imaging Devices Market include Derma Medical Systems, Danaher Corporation, Nikon Corporation, Canfield Scientific Inc., FotoFinder Systems GmbH, Carl Zeiss Meditec AG, 3Gen DermLite, Metaoptima Technology Inc., Strata Skin Sciences Company, Heine Optotechnik GmbH & Co. KG, Lucid Inc., ModiQuest Research and Michelson Diagnostics Company.
In October 2023, Danaher Corporation, has launched the patent-pending CellXpress.ai(TM) Automated Cell Culture System-an end-to-end, machine learning-enabled solution that automates demanding feeding and passaging schedules with an integrated incubator, liquid handler, and imager, giving scientists more time and autonomy in the lab.
In April 2023, Nikon Corporation announced the development and launch of the digital imaging microscope "ECLIPSE Ui"*2 as the first-ever microscope for medical use in Japan. The ECLIPSE Ui has a unique design without an eyepiece lens (even though is a microscope), a design which improves the pathologist's observation posture and enables the sharing of observation images on the display.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.